New bronchoscopy treatment for COPD
Part of Lungs & breathing clinical trials.
This trial tests a new bronchoscopy treatment for people with chronic obstructive pulmonary disease (COPD) who have had flare-ups. It aims to find if this treatment can help reduce symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diagnosed COPD that causes symptoms
- You have had COPD flare-ups in the past
- Your current medicines for COPD are stable and working
- Your doctor says you are healthy enough for a bronchoscopy procedure
- You do not smoke or vape any tobacco, nicotine, or other substances
- You do not have other serious health problems like unstable heart disease or uncontrolled diabetes
- You are not pregnant, nursing, or planning to get pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special radiofrequency treatment delivered through a bronchoscope (a thin camera tube) is safe and works better than standard care for people with COPD. It focuses on people with moderate-to-severe COPD symptoms who can follow study visits and tests.
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
This trial tests an investigational drug called R-3750 in patients with mild to moderate COPD. It aims to see if the drug is safe and helps control symptoms. Eligible patients must have had COPD for at least a year, have mild to moderate airflow limitation, and have had at least one COPD flare-up in the past year.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.